Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardial Stunning | 2 | 2025 | 17 | 0.990 |
Why?
|
| Myocardium | 5 | 2025 | 852 | 0.970 |
Why?
|
| Myocardial Reperfusion Injury | 3 | 2025 | 130 | 0.910 |
Why?
|
| Reactive Oxygen Species | 2 | 2025 | 521 | 0.890 |
Why?
|
| Epigenesis, Genetic | 2 | 2025 | 757 | 0.750 |
Why?
|
| Sitagliptin Phosphate | 1 | 2018 | 9 | 0.570 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2018 | 22 | 0.570 |
Why?
|
| Protective Agents | 1 | 2018 | 33 | 0.560 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2018 | 30 | 0.560 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2016 | 137 | 0.450 |
Why?
|
| Ischemic Preconditioning, Myocardial | 2 | 2025 | 13 | 0.440 |
Why?
|
| Proteomics | 3 | 2025 | 615 | 0.370 |
Why?
|
| ST Elevation Myocardial Infarction | 2 | 2024 | 117 | 0.350 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 2121 | 0.350 |
Why?
|
| Disease Models, Animal | 4 | 2025 | 4697 | 0.350 |
Why?
|
| Rats | 6 | 2025 | 3370 | 0.300 |
Why?
|
| Octreotide | 2 | 2025 | 23 | 0.280 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2016 | 895 | 0.270 |
Why?
|
| Animals | 11 | 2025 | 33912 | 0.240 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 1459 | 0.230 |
Why?
|
| Radiation-Protective Agents | 1 | 2025 | 19 | 0.230 |
Why?
|
| Ischemic Preconditioning | 1 | 2025 | 22 | 0.220 |
Why?
|
| Estrous Cycle | 1 | 2025 | 40 | 0.220 |
Why?
|
| Radiopharmaceuticals | 1 | 2025 | 152 | 0.220 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2024 | 14 | 0.220 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2025 | 82 | 0.210 |
Why?
|
| Myocardial Contraction | 1 | 2025 | 241 | 0.210 |
Why?
|
| Radiation Injuries | 1 | 2025 | 141 | 0.210 |
Why?
|
| Blood Proteins | 1 | 2024 | 143 | 0.200 |
Why?
|
| Proteome | 1 | 2025 | 285 | 0.190 |
Why?
|
| Ovariectomy | 2 | 2025 | 152 | 0.180 |
Why?
|
| Neuroendocrine Tumors | 1 | 2023 | 70 | 0.180 |
Why?
|
| Kidney Diseases | 1 | 2025 | 477 | 0.170 |
Why?
|
| Histones | 1 | 2024 | 541 | 0.160 |
Why?
|
| Myocardial Ischemia | 1 | 2023 | 307 | 0.160 |
Why?
|
| Oxidative Stress | 1 | 2024 | 791 | 0.150 |
Why?
|
| Myocardial Infarction | 2 | 2025 | 999 | 0.150 |
Why?
|
| Kidney | 1 | 2025 | 1282 | 0.140 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2018 | 20 | 0.140 |
Why?
|
| TRPV Cation Channels | 1 | 2018 | 42 | 0.140 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2018 | 77 | 0.140 |
Why?
|
| DNA Methylation | 1 | 2024 | 1077 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2018 | 186 | 0.130 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2017 | 10 | 0.130 |
Why?
|
| Hydrogen Sulfide | 1 | 2017 | 8 | 0.130 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2017 | 24 | 0.130 |
Why?
|
| Physical Conditioning, Animal | 1 | 2018 | 84 | 0.130 |
Why?
|
| Ventricular Remodeling | 1 | 2018 | 155 | 0.130 |
Why?
|
| Biomarkers | 3 | 2025 | 3385 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 887 | 0.120 |
Why?
|
| Colitis | 1 | 2017 | 166 | 0.110 |
Why?
|
| Up-Regulation | 1 | 2017 | 825 | 0.110 |
Why?
|
| Calcium | 1 | 2018 | 1010 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2025 | 1105 | 0.090 |
Why?
|
| Blood Glucose | 1 | 2016 | 1117 | 0.090 |
Why?
|
| Humans | 6 | 2025 | 131163 | 0.070 |
Why?
|
| Mice | 3 | 2025 | 18301 | 0.070 |
Why?
|
| Rats, Wistar | 2 | 2018 | 299 | 0.060 |
Why?
|
| Alpha-Globulins | 1 | 2025 | 8 | 0.060 |
Why?
|
| Radioisotopes | 1 | 2025 | 26 | 0.060 |
Why?
|
| Male | 5 | 2025 | 64957 | 0.060 |
Why?
|
| Orchiectomy | 1 | 2025 | 47 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2025 | 732 | 0.050 |
Why?
|
| Creatinine | 1 | 2025 | 398 | 0.050 |
Why?
|
| Aspartate Aminotransferase, Cytoplasmic | 1 | 2023 | 1 | 0.050 |
Why?
|
| Necrosis | 1 | 2023 | 192 | 0.050 |
Why?
|
| Estradiol | 1 | 2025 | 460 | 0.050 |
Why?
|
| Troponin I | 1 | 2023 | 122 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2025 | 1319 | 0.040 |
Why?
|
| Troponin T | 1 | 2023 | 259 | 0.040 |
Why?
|
| Sex Factors | 1 | 2025 | 1356 | 0.040 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2018 | 11 | 0.030 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2018 | 66 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2018 | 86 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2018 | 110 | 0.030 |
Why?
|
| Tyrosine | 1 | 2018 | 142 | 0.030 |
Why?
|
| Glutathione | 1 | 2018 | 200 | 0.030 |
Why?
|
| Female | 4 | 2025 | 70963 | 0.030 |
Why?
|
| Models, Animal | 1 | 2017 | 450 | 0.030 |
Why?
|
| Estrogens | 1 | 2018 | 434 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 301 | 0.030 |
Why?
|
| Colon | 1 | 2017 | 373 | 0.030 |
Why?
|
| Inflammation | 1 | 2017 | 1489 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 21025 | 0.010 |
Why?
|
| Middle Aged | 1 | 2024 | 28601 | 0.010 |
Why?
|